Assignee
RANA THERAPEUTICS INC
US·1 granted patent·21 pending applications·12 citations·filing 2013–2015
Top patents by PatentIndex Score
22 records- 0193US9668980B2Encapsulation of messenger RNARANA THERAPEUTICS INC·Filed 2015·Granted Jun 6, 2017·12 cites·16 claims
- 0258US2015247141A1Multimeric oligonucleotide compoundsRANA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 0354US2015050738A1Compositions and methods for modulating rnaRANA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 0453US2015152410A1Compositions and methods for modulating mecp2 expressionRANA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 0551US2015225715A13' targeting oligonucleotides for modulating rnaRANA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 0651US2015232846A1Pseudocircularization oligonucleotides for modulating rnaRANA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 0751US2015247144A1Methods for modulating rna using pseudocircularization oligonucleotidesRANA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 0851US2017152511A95' targeting oligonucleotides for modulating rnaRANA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 0951US2015232844A1Methods for modulating rna using 5' targeting oligonucleotidesRANA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1051US2015232847A1Targeting oligonucleotides and related methods for modulating fxn rnaRANA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1151US2015247145A1Methods for modulating rna using 3' targeting oligonucleotidesRANA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1248US2015133362A1Compositions and methods for modulating gene expressionRANA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1344US2015159161A1Compositions and methods for modulating pten expressionRANA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1444US2015141320A1Compositions and methods for modulating gene expressionRANA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1542US2016122760A1Compositions and methods for modulating foxp3 expressionRANA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1640US2015232836A1Compositions and methods for modulating gene expressionRANA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1740US2015191722A1Compositions and methods for modulating apoa1 and abca1 expressionRANA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1840US2015133529A1Compositions and methods for modulating bdnf expressionRANA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1939US2015218560A1Compositions for modulating gene expressionRANA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2038US2016201064A1Compositions and methods for modulating expression of frataxinRANA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2138US2016201063A1Epigenetic regulators of frataxinRANA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2223US2015225722A1Methods for selective targeting of heterochromatin forming non-coding rnaRANA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when RANA THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →